Amsterdam, 7 February 2024 EXOR ANNOUNCES THE PRICING OF EURO 650 MILLION NOTES MATURING IN 2033 Exor N.V. (rated A- with stable outlook by Standard & Poor’s) announces the pricing of Euro 650 million notes due on 14 February 2033, with an issue price of 99.371% and a fixed annual coupon of 3.75%. The purpose of the issue is to raise new funds for Exor’s general corporate purposes and refinance debt maturing in 2024. The notes will be listed on the Luxembourg Stock Exchange, admitted for trading on the Euro MTF Market, and the settlement of the issue will take place on 14 February 2024. This press release is not, and shall not contain or constitute, an offer to sell or a solicitation of an offer to buy or subscribe for the notes, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful or restricted by law. No action has been or will be taken to permit a public offering of the notes in any jurisdiction. The notes may not be offered or sold in the United States of America or to or for the account or benefit of U.S. persons (as such term is defined in Regulation S under the U.S. Securities Act as amended (the “Securities Act”)) unless registered under the U.S. Securities Act or pursuant to an exemption from such registration. Such notes have not been, nor will be, registered under the U.S. Securities Act or any other securities laws. No offering of the securities referred to herein will be made, directly or indirectly, in or into, or by use of the mail of, or by any means or instrumentality of interstate or foreign commerce of or of any facilities of a national securities exchange of, the United States of America. Not for release, publication, distribution or forwarding, in whole or in part, directly or indirectly, in or into the United States of America, its territories and possessions (including Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, Wake Island and the Northern Mariana islands, any state of the United States and the district of Columbia) (together, the “United States”) or to any person located or resident in the United States or in or into Australia, Canada, Japan, South Africa or any other jurisdiction in which such distribution would be prohibited by applicable law. Attachment Exor Press Release - Pricing Announcement
Exor Press Release - Pricing Announcement
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...